Drug Approval | December 05, 2022
Zydus receives final approval from USFDA for Estradiol Transdermal System
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad
Diclofenac Sodium Topical Solution USP, 2% w/w has an estimated market size of US $512 million for twelve months ending Sep 2022 according to IQVIA
Topiramate Extended-Release capsule had annual sales of US $68.8 mn in the United States according to IQVIA data (IQVIA MAT Sep 2022)
This product is based on Osmotic Controlled Release Oral Delivery System technology
To fund the upfront payment, Biocon Biologics has secured USD 1.2 billion of Sustainability Linked Loan
The Business Undertaking of Watson is engaged in the business of developing, manufacturing, marketing and sale of API.
The acquired brands are well established and recognized among doctors and other members of the medical fraternity in Brazil for their reliability, safety, and trustworthiness
The drug will be manufactured at the group's injectable manufacturing facility at Jarod, near Vadodara, India
The two have agreed to jointly undertake R&D activities on scientific validation of Ayush concepts, procedures and products
It serves to leverage the strengths of various institutions to coordinate AMR surveillance lab networks
Subscribe To Our Newsletter & Stay Updated
